Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04139304
Title A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AIDS Malignancy Consortium
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami Miller School of Medicine Miami Florida 33136 United States Details
University of Illinois at Chicago Chicago Illinois 60612 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21231 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10021 United States Details
University of North Carolina - Chapel Hill Chapel Hill North Carolina 27514 United States Details
The Ohio State University Columbus Ohio 43210 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field